health canada approval zepbound tirzepatide obesity canada 2024 2025 Just In: is now available for weight loss in Canada!⁣ ⁣ This new GLP-1 medication offers science-backed support for long-term, sustainable results — when used under medical supervision.⁣ ⁣ ✓ Ask Zepbound vs Wegovy: Zepbound 20%

If you take this GLP-1, you can get rid of one or two blood pressure medicines

Next was semaglutide, marketed as Wegovy for weight management, and as Ozempic and Rybelsus for diabetes, and then tirzepatide, marketed as Zepbound for weight management, and as Mounjaro for diabetes

Clinical trials have shown that tirzepatide produces substantial weight loss in patients with obesity, often exceeding results seen with other medications in the same class

RETA improved glucose tolerance compared to baseline tolerance tests at the start of the study, as well as compared to Veh at study midpoint (Supplementary Figs

[Some] people really struggle with acceptance of the way their bodies look and the number the scale reads even after this weight loss success, she says

For a deeper look at results timelines, the before and after guide shows real-world outcomes at various timepoints, and the male-specific results article covers gender-specific patterns